The DPT vaccine or DTP vaccine is a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.The vaccine components include diphtheria and tetanus toxoids and either killed whole cells of the bacterium that causes pertussis or pertussis antigens.
Due to the COVID-19 pandemic, the global Diphtheria Tetanus Pertussis Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Diphtheria Tetanus Pertussis Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Diphtheria Tetanus Pertussis Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
DTwP Type accounting for % of the Diphtheria Tetanus Pertussis Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Child segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Diphtheria Tetanus Pertussis Vaccine include Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), MCM Vaccine, Merck, MassBiologics, Bionet-Asia and Amson Vaccines & Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Diphtheria Tetanus Pertussis Vaccine in 2021.
This report focuses on Diphtheria Tetanus Pertussis Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Diphtheria Tetanus Pertussis Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Diphtheria Tetanus Pertussis Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
DTwP Type
DTaP Type
Segment by Application
Child
Teenager
Aldult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
BioKangtai
China National Biotec
Chengdu Oulin Biological Science&Technology